United Therapeutics Corporation Income (Loss) from Equity Method Investments
United Therapeutics Corporation (UTHR) reported Income (Loss) from Equity Method Investments of -$72.00 thousand for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-07-25.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2013-07-25
- United Therapeutics Corporation income (loss) from equity method investments for the quarter ending 2013-06-30 was -$72.00K.
- United Therapeutics Corporation income (loss) from equity method investments for the quarter ending 2013-03-31 was -$47.00K.
- United Therapeutics Corporation income (loss) from equity method investments for the quarter ending 2012-12-31 was -$33.00K.
- United Therapeutics Corporation income (loss) from equity method investments for the quarter ending 2012-09-30 was -$48.00K.
- United Therapeutics Corporation income (loss) from equity method investments for fiscal 2012 was -$143.00K.
- United Therapeutics Corporation income (loss) from equity method investments for fiscal 2011 was -$119.00K.
- United Therapeutics Corporation income (loss) from equity method investments for fiscal 2010 was -$160.00K.
- United Therapeutics Corporation income (loss) from equity method investments for fiscal 2009 was -$141.00K.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2013-06-30 | -$72.00K 10-Q · filed 2013-07-25 | -$119.00K 10-Q · filed 2013-07-25 | -$152.00K derived: sum of 3 quarters · filed 2013-07-25 | -$200.00K derived: sum of 4 quarters · filed 2013-07-25 |
| 2013-03-31 | -$47.00K 10-Q · filed 2013-04-25 | -$80.00K derived: sum of 2 quarters · filed 2013-04-25 | -$128.00K derived: sum of 3 quarters · filed 2013-04-25 | -$170.00K derived: sum of 4 quarters · filed 2013-07-25 |
| 2012-12-31 | -$33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$81.00K derived: sum of 2 quarters · filed 2013-02-26 | -$123.00K derived: sum of 3 quarters · filed 2013-07-25 | -$143.00K 10-K · filed 2013-02-26 |
| 2012-09-30 | -$48.00K 10-Q · filed 2012-11-01 | -$90.00K derived: sum of 2 quarters · filed 2013-07-25 | -$110.00K 10-Q · filed 2012-11-01 | -$119.00K derived: sum of 4 quarters · filed 2013-07-25 |
| 2012-06-30 | -$42.00K 10-Q · filed 2013-07-25 | -$62.00K 10-Q · filed 2013-07-25 | -$71.00K derived: sum of 3 quarters · filed 2013-07-25 | -$114.00K derived: sum of 4 quarters · filed 2013-07-25 |
| 2012-03-31 | -$20.00K 10-Q · filed 2013-04-25 | -$29.00K derived: sum of 2 quarters · filed 2013-04-25 | -$72.00K derived: sum of 3 quarters · filed 2013-04-25 | -$102.00K derived: sum of 4 quarters · filed 2013-04-25 |
| 2011-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$52.00K derived: sum of 2 quarters · filed 2013-02-26 | -$82.00K derived: sum of 3 quarters · filed 2013-02-26 | -$119.00K 10-K · filed 2013-02-26 |
| 2011-09-30 | -$43.00K 10-Q · filed 2012-11-01 | -$73.00K derived: sum of 2 quarters · filed 2012-11-01 | -$110.00K 10-Q · filed 2012-11-01 | -$140.00K derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | -$30.00K 10-Q · filed 2012-07-26 | -$67.00K 10-Q · filed 2012-07-26 | -$97.00K derived: sum of 3 quarters · filed 2013-02-26 | -$136.00K derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-03-31 | -$37.00K 10-Q · filed 2012-04-26 | -$67.00K derived: sum of 2 quarters · filed 2013-02-26 | -$106.00K derived: sum of 3 quarters · filed 2013-02-26 | -$150.00K derived: sum of 4 quarters · filed 2013-02-26 |
| 2010-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$69.00K derived: sum of 2 quarters · filed 2013-02-26 | -$113.00K derived: sum of 3 quarters · filed 2013-02-26 | -$160.00K 10-K · filed 2013-02-26 |
| 2010-09-30 | -$39.00K 10-Q · filed 2011-10-27 | -$83.00K derived: sum of 2 quarters · filed 2011-10-27 | -$130.00K 10-Q · filed 2011-10-27 | -$172.00K derived: sum of 4 quarters · filed 2012-02-28 |
| 2010-06-30 | -$44.00K 10-Q · filed 2011-07-28 | -$91.00K 10-Q · filed 2011-07-28 | -$133.00K derived: sum of 3 quarters · filed 2012-02-28 | -$175.00K derived: sum of 4 quarters · filed 2012-02-28 |
| 2010-03-31 | -$47.00K 10-Q · filed 2011-04-28 | -$89.00K derived: sum of 2 quarters · filed 2012-02-28 | -$131.00K derived: sum of 3 quarters · filed 2012-02-28 | -$169.00K derived: sum of 4 quarters · filed 2012-02-28 |
| 2009-12-31 | -$42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$84.00K derived: sum of 2 quarters · filed 2012-02-28 | -$122.00K derived: sum of 3 quarters · filed 2012-02-28 | -$141.00K 10-K · filed 2012-02-28 |
| 2009-09-30 | -$42.00K 10-Q · filed 2010-10-28 | -$80.00K derived: sum of 2 quarters · filed 2010-10-28 | -$99.00K 10-Q · filed 2010-10-28 | |
| 2009-06-30 | -$38.00K 10-Q · filed 2010-07-28 | -$57.00K 10-Q · filed 2010-07-28 | ||
| 2008-12-31 | -$226.00K 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |